Medivir AB Release: The Nomination Committee’s Proposal, With Reference To The Upcoming 2014 Annual General Meeting, For A New Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Stockholm, Sweden — Medivir AB (OMX: MVIR) announced today the Nomination Committee’s proposal, with reference to the upcoming 2014 Annual General Meeting, for a new Board of Directors. The 2013-2014 Nomination Committee comprises representatives of the three largest shareholders in the company at the end of the third quarter of 2013 who have accepted a seat on the Nomination Committee, together with the Chairman of the Board. The composition of the 2013 -2014 Nomination Committee was as follows:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC